These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11862314)

  • 1. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
    Wonerow P; Neumann S; Gudermann T; Paschke R
    J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.
    Szkudlinski MW; Fremont V; Ronin C; Weintraub BD
    Physiol Rev; 2002 Apr; 82(2):473-502. PubMed ID: 11917095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders caused by mutations of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 1998 Jul; 56(7):1856-60. PubMed ID: 9702065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine 390 mutation of the TSH receptor modulates its ectodomain as an inverse agonist on the serpentine domain with decrease in basal constitutive activity.
    Ho SC; Goh SS; Su Q; Khoo DH
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):158-68. PubMed ID: 16364538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
    Krause K; Boisnard A; Ihling C; Ludgate M; Eszlinger M; Krohn K; Sinz A; Fuhrer D
    Int J Biochem Cell Biol; 2012 Feb; 44(2):290-301. PubMed ID: 22074661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.
    Jaeschke H; Schaarschmidt J; Günther R; Mueller S
    Endocrinology; 2011 Oct; 152(10):3986-96. PubMed ID: 21846801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
    Lado-Abeal J; Quisenberry LR; Castro-Piedras I
    Methods Enzymol; 2010; 484():375-95. PubMed ID: 21036242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin receptor-associated diseases: from adenomata to Graves disease.
    Davies TF; Ando T; Lin RY; Tomer Y; Latif R
    J Clin Invest; 2005 Aug; 115(8):1972-83. PubMed ID: 16075037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure-function relations of glycoprotein hormone receptors and their medical applications].
    Costagliola S
    Bull Mem Acad R Med Belg; 2004; 159(5-6):367-75. PubMed ID: 15693546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
    Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively activating mutations of the thyrotropin receptor and thyroid disease.
    Führer D; Holzapfel HP; Wonerow P; Paschke R
    Eur J Med Res; 1996 Jul; 1(10):460-4. PubMed ID: 9438142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling.
    Latif R; Morshed SA; Zaidi M; Davies TF
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):319-41, viii. PubMed ID: 19328414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activities in the thyrotropin receptor: regulation and significance.
    Kleinau G; Biebermann H
    Adv Pharmacol; 2014; 70():81-119. PubMed ID: 24931193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
    Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.
    Duprez L; Parma J; Van Sande J; Allgeier A; Leclère J; Schvartz C; Delisle MJ; Decoulx M; Orgiazzi J; Dumont J
    Nat Genet; 1994 Jul; 7(3):396-401. PubMed ID: 7920658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TSH receptors and signal transduction].
    Kawakami Y; Fujita R; Okuda Y; Yamashita K
    Nihon Rinsho; 1993 Oct; 51(10):2649-54. PubMed ID: 8254934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.